Diabetes and outcomes following guided de-escalation of antiplatelet treatment in acute coronary syndrome patients undergoing percutaneous coronary intervention: a pre-specified analysis from the randomised TROPICAL-ACS trial.

Abstract

A guided de-escalation of P2Y12 inhibitor treatment is considered an alternative treatment strategy in ACS patients undergoing PCI. However, the safety and efficacy of this strategy may differ in diabetic vs non-diabetic patients. The aim of this study was to compare the outcomes of platelet function testing (PFT)-guided de-escalation of dual antiplatelet therapy (DAPT) in ACS patients with and without diabetes mellitus.

Journal

Journal ID (iso-abbrev): EuroIntervention

Title: EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology

Publisher: Europa Digital & Publishing

ISSN (Electronic): 1969-6213

ISSN (Print): 1774-024X

Publication date (Electronic): August 09 2019

Volume: 15

Issue: 6

Affiliations

[1 ] Ludwig-Maximilians University, Department of Cardiology, Munich, Germany.

Article

Publisher Item ID: EIJ-D-18-01077

DOI: 10.4244/EIJ-D-18-01077

PubMed ID: 31012853

SO-VID: 574b6119-39d9-4602-b87d-8b120bc40e0f